Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Polymerases
Revenue, means the sales value of Polymerases
This report studies sales (consumption) of Polymerases in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Thermo Fisher Scientific, Inc. (U.S.)
Merck KGaA (Germany)
New England Biolabs, Inc. (U.S.)
Promega (U.S.)
Illumina, Inc. (U.S.)
Agilent Technologies, Inc. (U.S.)
F. Hoffmann-la Roche Ltd. (Switzerland)
Takara Bio Inc. (Japan)
QIAGEN N.V. (The Netherlands)
Becton, Dickinson and Company (U.S.)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Polymerases in each application, can be divided into
PCR
Sequencing
Cloning
United States Polymerases Market Report 2016
1 Polymerases Overview
1.1 Product Overview and Scope of Polymerases
1.2 Classification of Polymerases
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Polymerases
1.3.1 PCR
1.3.2 Sequencing
1.3.3 Cloning
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Polymerases (2011-2021)
1.4.1 United States Polymerases Sales and Growth Rate (2011-2021)
1.4.2 United States Polymerases Revenue and Growth Rate (2011-2021)
2 United States Polymerases Competition by Manufacturers
2.1 United States Polymerases Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Polymerases Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Polymerases Average Price by Manufactures (2015 and 2016)
2.4 Polymerases Market Competitive Situation and Trends
2.4.1 Polymerases Market Concentration Rate
2.4.2 Polymerases Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Polymerases Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Polymerases Sales and Market Share by Type (2011-2016)
3.2 United States Polymerases Revenue and Market Share by Type (2011-2016)
3.3 United States Polymerases Price by Type (2011-2016)
3.4 United States Polymerases Sales Growth Rate by Type (2011-2016)
4 United States Polymerases Sales (Volume) by Application (2011-2016)
4.1 United States Polymerases Sales and Market Share by Application (2011-2016)
4.2 United States Polymerases Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Polymerases Manufacturers Profiles/Analysis
5.1 Thermo Fisher Scientific, Inc. (U.S.)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Polymerases Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Thermo Fisher Scientific, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Merck KGaA (Germany)
5.2.2 Polymerases Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Merck KGaA (Germany) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 New England Biolabs, Inc. (U.S.)
5.3.2 Polymerases Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 New England Biolabs, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Promega (U.S.)
5.4.2 Polymerases Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Promega (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Illumina, Inc. (U.S.)
5.5.2 Polymerases Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Illumina, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Agilent Technologies, Inc. (U.S.)
5.6.2 Polymerases Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Agilent Technologies, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 F. Hoffmann-la Roche Ltd. (Switzerland)
5.7.2 Polymerases Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 F. Hoffmann-la Roche Ltd. (Switzerland) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Takara Bio Inc. (Japan)
5.8.2 Polymerases Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Takara Bio Inc. (Japan) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 QIAGEN N.V. (The Netherlands)
5.9.2 Polymerases Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 QIAGEN N.V. (The Netherlands) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Becton, Dickinson and Company (U.S.)
5.10.2 Polymerases Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Becton, Dickinson and Company (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Polymerases Manufacturing Cost Analysis
6.1 Polymerases Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Polymerases
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Polymerases Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Polymerases Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Polymerases Market Forecast (2016-2021)
10.1 United States Polymerases Sales, Revenue Forecast (2016-2021)
10.2 United States Polymerases Sales Forecast by Type (2016-2021)
10.3 United States Polymerases Sales Forecast by Application (2016-2021)
10.4 Polymerases Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Polymerases
Table Classification of Polymerases
Figure United States Sales Market Share of Polymerases by Type in 2015
Table Application of Polymerases
Figure United States Sales Market Share of Polymerases by Application in 2015
Figure PCR Examples
Figure Sequencing Examples
Figure Cloning Examples
Figure United States Polymerases Sales and Growth Rate (2011-2021)
Figure United States Polymerases Revenue and Growth Rate (2011-2021)
Table United States Polymerases Sales of Key Manufacturers (2015 and 2016)
Table United States Polymerases Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Polymerases Sales Share by Manufacturers
Figure 2016 Polymerases Sales Share by Manufacturers
Table United States Polymerases Revenue by Manufacturers (2015 and 2016)
Table United States Polymerases Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Polymerases Revenue Share by Manufacturers
Table 2016 United States Polymerases Revenue Share by Manufacturers
Table United States Market Polymerases Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Polymerases Average Price of Key Manufacturers in 2015
Figure Polymerases Market Share of Top 3 Manufacturers
Figure Polymerases Market Share of Top 5 Manufacturers
Table United States Polymerases Sales by Type (2011-2016)
Table United States Polymerases Sales Share by Type (2011-2016)
Figure United States Polymerases Sales Market Share by Type in 2015
Table United States Polymerases Revenue and Market Share by Type (2011-2016)
Table United States Polymerases Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Polymerases by Type (2011-2016)
Table United States Polymerases Price by Type (2011-2016)
Figure United States Polymerases Sales Growth Rate by Type (2011-2016)
Table United States Polymerases Sales by Application (2011-2016)
Table United States Polymerases Sales Market Share by Application (2011-2016)
Figure United States Polymerases Sales Market Share by Application in 2015
Table United States Polymerases Sales Growth Rate by Application (2011-2016)
Figure United States Polymerases Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Polymerases Sales Market Share (2011-2016)
Table Merck KGaA (Germany) Basic Information List
Table Merck KGaA (Germany) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGaA (Germany) Polymerases Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Polymerases Sales Market Share (2011-2016)
Table Promega (U.S.) Basic Information List
Table Promega (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Promega (U.S.) Polymerases Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Polymerases Sales Market Share (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Basic Information List
Table Agilent Technologies, Inc. (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies, Inc. (U.S.) Polymerases Sales Market Share (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-la Roche Ltd. (Switzerland) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-la Roche Ltd. (Switzerland) Polymerases Sales Market Share (2011-2016)
Table Takara Bio Inc. (Japan) Basic Information List
Table Takara Bio Inc. (Japan) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takara Bio Inc. (Japan) Polymerases Sales Market Share (2011-2016)
Table QIAGEN N.V. (The Netherlands) Basic Information List
Table QIAGEN N.V. (The Netherlands) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table QIAGEN N.V. (The Netherlands) Polymerases Sales Market Share (2011-2016)
Table Becton, Dickinson and Company (U.S.) Basic Information List
Table Becton, Dickinson and Company (U.S.) Polymerases Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton, Dickinson and Company (U.S.) Polymerases Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polymerases
Figure Manufacturing Process Analysis of Polymerases
Figure Polymerases Industrial Chain Analysis
Table Raw Materials Sources of Polymerases Major Manufacturers in 2015
Table Major Buyers of Polymerases
Table Distributors/Traders List
Figure United States Polymerases Production and Growth Rate Forecast (2016-2021)
Figure United States Polymerases Revenue and Growth Rate Forecast (2016-2021)
Table United States Polymerases Production Forecast by Type (2016-2021)
Table United States Polymerases Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...